Related references
Note: Only part of the references are listed.RNAi therapeutics for CNS disorders
Ryan L. Boudreau et al.
BRAIN RESEARCH (2010)
Small Non-Coding RNAs as Novel Therapeutics
M. Rossbach
CURRENT MOLECULAR MEDICINE (2010)
MicroRNA Loss Enhances Learning and Memory in Mice
Witold Konopka et al.
JOURNAL OF NEUROSCIENCE (2010)
Regulation of Opioid Tolerance by let-7 Family MicroRNA Targeting the μ Opioid Receptor
Ying He et al.
JOURNAL OF NEUROSCIENCE (2010)
Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression
Stephan Gehrke et al.
NATURE (2010)
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Mark E. Davis et al.
NATURE (2010)
MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders
Albert H. Kim et al.
SCHIZOPHRENIA RESEARCH (2010)
MiR-16 Targets the Serotonin Transporter: A New Facet for Adaptive Responses to Antidepressants
Anne Baudry et al.
SCIENCE (2010)
Potential application of RNAi for understanding and therapy of neurodegenerative diseases
Elena I. Schwartz
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Micro-RNA abundance and stability in human brain: Specific alterations in Alzheimer's disease temporal lobe neocortex
Prerna Sethi et al.
NEUROSCIENCE LETTERS (2009)
MicroRNAs (miRNAs) in neurodegenerative diseases
Peter T. Nelson et al.
BRAIN PATHOLOGY (2008)
MicroRNA: an emerging therapeutic target and intervention tool
Zhen Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2008)
MicroRNA expression in the adult mouse central nervous system
Mads Bak et al.
RNA (2008)
Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus
Walter J. Lukiw
NEUROREPORT (2007)
Therapeutic RNA interference for neurodegenerative diseases: From promise to progress
Pedro Gonzalez-Alegre
PHARMACOLOGY & THERAPEUTICS (2007)
Review of the application of RNA interference technology in the pharmaceutical industry
Henny M. Martineau et al.
TOXICOLOGIC PATHOLOGY (2007)
Low cerebrospinal fluid transthyretin levels in depression: Correlations with suicidal ideation and low serotonin function
Gregory M. Sullivan et al.
BIOLOGICAL PSYCHIATRY (2006)
Share Paper
